Business Information
The group's principal activity is to develop, manufacture and market disposable diagnostic test kits for rapid diagnosis of infectious diseases. The group's operating segments are classified as, us diagnostics, European diagnostics and life science. The us diagnostics segment focuses on the development, manufacture and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases. The European diagnostics segment focuses on the sale and distribution of diagnostic test kits, manufactured by the us diagnostics operating segment and others manufactured by third-party vendors. The life science segment focuses on the development, manufacture, sale and distribution of bulk antigens and reagents used by researchers and other diagnostic companies, as well as the contract manufacturing of proteins and other biologicals used by biopharmaceutical and biotechnology companies.
|
|
Name |
Title
|
Email
|
| William Motto | Exec. Chmn. | N/A | | John Kraeutler | Dir., CEO | N/A | | Melissa Lueke | CFO, VP | N/A | | Antonio Interno | Sr. VP, Pres., MD - Meridian Bioscience Europe | N/A | | Grady Barnes | VP - Research - Product Development | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 108,413 | 18,325 | | 2005 | 92,965 | 12,565 | | 2004 | 79,606 | 9,185
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
